Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4091844 | 1.00 | PTGER1 (1.00) | PTGER1 | |
| Hydrochloric Acid SCHEMBL4104578 | 0.99 | PTGER1 (1.00) | PTGER1 | |
| SCHEMBL13693324 | 0.95 | PTGER1 (0.98) | PTGER1 | |
| Hydrochloric Acid SCHEMBL4096755 | 0.95 | PTGER1 (1.00) | PTGER1 | |
| SCHEMBL3056778 | 0.91 | PTGER1 (0.84) | PTGER1 | |
| Hydrochloric Acid SCHEMBL3056914 | 0.90 | PTGER1 (0.84) | PTGER1 | |
| SCHEMBL3578834 | 0.90 | PTGER1 (0.81) | PTGER1 | |
| SCHEMBL3058104 | 0.90 | PTGER1 (0.81) | PTGER1 | |
| Hydrochloric Acid SCHEMBL3049776 | 0.89 | PTGER1 (0.82) | PTGER1 | |
| Hydrochloric Acid SCHEMBL3583126 | 0.89 | PTGER1 (0.82) | PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289794-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2025-09-18 | — | — | US | disclosed |
| US-12286413-B2 | Compounds and methods for treating cancer | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2025-04-29 | — | — | US | disclosed |
| EP-4180041-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | Mayo Foundation for Medical Education and Research (US) | 2023-05-17 | — | — | EP | disclosed |
| CN-113666853-B | Biaryl compounds useful as ROR gamma modulators | 上海辉启生物医药科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20220411389-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2022-12-29 | — | — | US | disclosed |
| EP-3808349-B1 | COMPOUNDS AND METHODS FOR TREATING CANCER | MAYO FOUND MEDICAL EDUCATION & RES (US) | 2022-10-05 | — | — | EP | disclosed |
| US-11325892-B2 | Compounds and methods for treating cancer | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2022-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325892-B2 | Compounds and methods for treating cancer | SCD, CPT1B, CPT1A | PTGER1 202/4885 |
| US-20250289794-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | SCD, CPT1B, CPT1A | PTGER1 202/4885 |
| US-20220411389-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | SCD, CPT1B, CPT1A | PTGER1 202/4885 |
| US-12286413-B2 | Compounds and methods for treating cancer | SCD, CPT1B, CPT1A | PTGER1 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.